Federal law lets fathers sue over abortion pills, expanding litigation beyond the woman
H.R. 5485 — Second Chance at Life Act of 2025 · Filed by August Pfluger (R-TX) · 23 cosponsors · Introduced Sep 18, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires abortion providers to inform women seeking chemical abortion (mifepristone followed by misoprostol) that the effects may be reversible if they change their mind, and to provide written discharge instructions and signage stating this. It mandates the Department of Health and Human Services create a website with reversal information and allows civil suits—including by the father of the unborn child—against providers who fail to comply, with attorney's fees to prevailing parties.
Why we flagged it
The bill's operative mechanism is a disclosure requirement (informed consent), but its most consequential feature is the creation of a private right of action allowing third parties—including biological fathers—to sue abortion providers for damages, which expands litigation exposure beyond the pregnant woman's own remedies.
What the text implies
- The private right of action extends to biological fathers and parents of minors, giving third parties standing to sue on behalf of an unborn child—a significant shift in abortion litigation from state enforcement to private civil suits, potentially creating a chilling effect on abortion provision.
- The bill mandates disclosure of 'reversal' information based on mifepristone reversal protocols (typically progesterone supplementation), but the medical evidence for efficacy is contested and not universally accepted by major medical organizations; mandating disclosure of contested medical claims may mislead women.
- Section 3406 allows suits for 'actual and punitive damages' without a cap, creating potentially unlimited liability for providers and making malpractice insurance more expensive or unavailable, which may reduce access to chemical abortion in rural or underserved areas.
- The bill preempts nothing—it explicitly allows states to impose MORE extensive disclosure and penalty requirements, creating a floor for federal mandates that states can build upon, potentially leading to a patchwork of increasingly restrictive disclosure regimes.
- The website requirement (Section 3405) mandates specific technical specifications (70 DPI, 200x300 pixel images, 12-point font) that appear designed to ensure a particular visual presentation of reversal information, suggesting intent to shape how the information is perceived rather than merely inform.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill creates new informed-consent disclosure requirements that may benefit women by providing information about a potential medical option, but simultaneously creates a private right of action allowing fathers and parents to sue abortion providers, which shifts power away from the pregnant woman and toward third parties, and the reversal claims rest on contested medical science.
Who stands to gain
- medical malpractice insurers (increased litigation exposure)
- abortion reversal clinics and practitioners (increased referrals from mandated disclosure)
- law firms specializing in abortion litigation
Named in the bill
Department of Health and Human Services, abortion providers, mifepristone, misoprostol, biological fathers, parents of minors
Where it stands
23 cosponsors: 23 Republicans.
- Sep 18, 2025 — Introduced · Congress.gov: “Introduced in House”
- Sep 18, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $420,000 in lobbying spend. A filing names 51 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
August Pfluger, the sponsor, reported $1,070,325 in PAC receipts in the 2026 cycle.
- Susan B Anthony List — $420,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (8,197 characters) on Aug 18, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Federal law lets fathers sue over abortion pills, expanding litigation beyond the woman” QuorumCivic. https://share.quorumcivic.app/bill/119/hr5485 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.